{"id":"https://openalex.org/W3095253468","doi":"https://doi.org/10.1182/blood-2020-138527","title":"CAR19 iPSC-Derived NK Cells Utilize the Innate Functional Potential Mediated through NKG2A-Driven Education and Override the HLA-E Check Point to Effectively Target B Cell Lymphoma","display_name":"CAR19 iPSC-Derived NK Cells Utilize the Innate Functional Potential Mediated through NKG2A-Driven Education and Override the HLA-E Check Point to Effectively Target B Cell Lymphoma","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3095253468","doi":"https://doi.org/10.1182/blood-2020-138527","mag":"3095253468"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-138527","doi":"https://doi.org/10.1182/blood-2020-138527","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-138527","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080128592","display_name":"Minoru Kanaya","orcid":"https://orcid.org/0000-0002-0035-8657","observed_orcids":["https://orcid.org/0000-0002-0035-8657"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Minoru Kanaya","raw_affiliation_strings":["Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075551071","display_name":"Camille Philippon","orcid":"https://orcid.org/0000-0001-5620-2195","observed_orcids":["https://orcid.org/0000-0001-5620-2195"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Camille Philippon","raw_affiliation_strings":["Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084664823","display_name":"Artur Cie\u015blar\u2010Pobuda","orcid":"https://orcid.org/0000-0002-4480-6749","observed_orcids":["https://orcid.org/0000-0002-4480-6749"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Artur Cieslar-Pobuda","raw_affiliation_strings":["Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023014242","display_name":"Frank M. Cichocki","orcid":"https://orcid.org/0000-0003-3043-0653","observed_orcids":["https://orcid.org/0000-0003-3043-0653"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Cichocki","raw_affiliation_strings":["Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027175862","display_name":"Michelle S\u00e6tersmoen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Michelle Saetersmoen","raw_affiliation_strings":["Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090528267","display_name":"Sajid Mahmood","orcid":"https://orcid.org/0000-0003-0684-0185","observed_orcids":["https://orcid.org/0000-0003-0684-0185"]},"institutions":[{"id":"https://openalex.org/I4210155835","display_name":"Fate Therapeutics (United States)","ror":"https://ror.org/04p6jwd33","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sajid Mahmood","raw_affiliation_strings":["Fate Therapeutics Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fate Therapeutics Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210155835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068728003","display_name":"Quirin Hammer","orcid":"https://orcid.org/0000-0003-2968-6061","observed_orcids":["https://orcid.org/0000-0003-2968-6061"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Quirin Hammer","raw_affiliation_strings":["Center for Infectious Medicine, Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Infectious Medicine, Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050786730","display_name":"Marianna Vincenti","orcid":"https://orcid.org/0000-0001-5361-0185","observed_orcids":["https://orcid.org/0000-0001-5361-0185"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Marianna Vincenti","raw_affiliation_strings":["Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004342251","display_name":"Merete Thune Wiiger","orcid":"https://orcid.org/0000-0003-4833-3237","observed_orcids":["https://orcid.org/0000-0003-4833-3237"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Merete Thune Wiiger","raw_affiliation_strings":["Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021412783","display_name":"Hanna Julie Hoel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Hanna Julie Hoel","raw_affiliation_strings":["Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025389228","display_name":"Lise Kveberg","orcid":"https://orcid.org/0000-0001-9308-0641","observed_orcids":["https://orcid.org/0000-0001-9308-0641"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Lise Kveberg","raw_affiliation_strings":["Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054016372","display_name":"Svetlana Gaidarova","orcid":"https://orcid.org/0000-0003-2793-8472","observed_orcids":["https://orcid.org/0000-0003-2793-8472"]},"institutions":[{"id":"https://openalex.org/I4210155835","display_name":"Fate Therapeutics (United States)","ror":"https://ror.org/04p6jwd33","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Svetlana Gaidarova","raw_affiliation_strings":["Fate Therapeutics Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fate Therapeutics Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210155835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011430525","display_name":"Ryan Bjordahl","orcid":"https://orcid.org/0000-0001-9277-3155","observed_orcids":["https://orcid.org/0000-0001-9277-3155"]},"institutions":[{"id":"https://openalex.org/I4210155835","display_name":"Fate Therapeutics (United States)","ror":"https://ror.org/04p6jwd33","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Bjordahl","raw_affiliation_strings":["Fate Therapeutics Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fate Therapeutics Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210155835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008300500","display_name":"Hui-Yi Chu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155835","display_name":"Fate Therapeutics (United States)","ror":"https://ror.org/04p6jwd33","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hui-yi Chu","raw_affiliation_strings":["Fate Therapeutics Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fate Therapeutics Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210155835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025807763","display_name":"Brian C. Groff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155835","display_name":"Fate Therapeutics (United States)","ror":"https://ror.org/04p6jwd33","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Groff","raw_affiliation_strings":["Fate Therapeutics Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fate Therapeutics Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210155835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069484325","display_name":"Matthew Denholtz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155835","display_name":"Fate Therapeutics (United States)","ror":"https://ror.org/04p6jwd33","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Denholtz","raw_affiliation_strings":["Fate Therapeutics Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fate Therapeutics Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210155835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027151969","display_name":"Jeffrey S. Miller","orcid":"https://orcid.org/0000-0002-0339-4944","observed_orcids":["https://orcid.org/0000-0002-0339-4944"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey S. Miller","raw_affiliation_strings":["Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103253648","display_name":"Tom Lee","orcid":"https://orcid.org/0000-0003-0805-4006","observed_orcids":["https://orcid.org/0000-0003-0805-4006"]},"institutions":[{"id":"https://openalex.org/I4210155835","display_name":"Fate Therapeutics (United States)","ror":"https://ror.org/04p6jwd33","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom Lee","raw_affiliation_strings":["Fate Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fate Therapeutics, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210155835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062734813","display_name":"Dan S. Kaufman","orcid":"https://orcid.org/0000-0002-2003-2494","observed_orcids":["https://orcid.org/0000-0002-2003-2494"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan S Kaufman","raw_affiliation_strings":["Department of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109787025","display_name":"Jode Goodridge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155835","display_name":"Fate Therapeutics (United States)","ror":"https://ror.org/04p6jwd33","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jode P Goodridge","raw_affiliation_strings":["Fate Therapeutics Inc., SAN DIEGO, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fate Therapeutics Inc., SAN DIEGO, CA","institution_ids":["https://openalex.org/I4210155835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070964738","display_name":"Bahram Bob Valamehr","orcid":"https://orcid.org/0000-0002-5917-3585","observed_orcids":["https://orcid.org/0000-0002-5917-3585"]},"institutions":[{"id":"https://openalex.org/I4210155835","display_name":"Fate Therapeutics (United States)","ror":"https://ror.org/04p6jwd33","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bahram Valamehr","raw_affiliation_strings":["Fate Therapeutics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fate Therapeutics, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210155835"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061606756","display_name":"Karl\u2010Johan Malmberg","orcid":"https://orcid.org/0000-0002-8718-9373","observed_orcids":["https://orcid.org/0000-0002-8718-9373"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["NO","SE"],"is_corresponding":false,"raw_author_name":"Karl-Johan Malmberg","raw_affiliation_strings":["Center for Infectious Medicine, Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden","Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Infectious Medicine, Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"136","issue":"Supplement 1","first_page":"34","last_page":"35"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ipsc-derived-nk-cells","display_name":"iPSC-derived NK cells","score":0.8809999823570251},{"id":"https://openalex.org/keywords/cd19-chimeric-antigen-receptor","display_name":"CD19 chimeric antigen receptor","score":0.828000009059906},{"id":"https://openalex.org/keywords/nk-cell-education","display_name":"NK cell education","score":0.7350000143051147},{"id":"https://openalex.org/keywords/nkg2a","display_name":"NKG2A","score":0.9570000171661377},{"id":"https://openalex.org/keywords/hla-e","display_name":"HLA-E","score":0.8009999990463257},{"id":"https://openalex.org/keywords/missing-self","display_name":"missing self","score":0.8679999709129333},{"id":"https://openalex.org/keywords/inhibitory-receptors","display_name":"inhibitory receptors","score":0.7390000224113464},{"id":"https://openalex.org/keywords/killer-cell-immunoglobulin-like-receptors","display_name":"killer cell immunoglobulin-like receptors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/nkg2c","display_name":"NKG2C","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.49300000071525574},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.8880000114440918},{"id":"https://openalex.org/keywords/nk-cell-degranulation","display_name":"NK cell degranulation","score":0.6359999775886536},{"id":"https://openalex.org/keywords/beta2-microglobulin","display_name":"beta2-microglobulin","score":0.7379999756813049},{"id":"https://openalex.org/keywords/nk-cell-expansion","display_name":"NK cell expansion","score":0.3630000054836273},{"id":"https://openalex.org/keywords/off-the-shelf-immunotherapy","display_name":"off-the-shelf immunotherapy","score":0.6800000071525574},{"id":"https://openalex.org/keywords/mass-cytometry","display_name":"mass cytometry","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6904196739196777},{"id":"https://openalex.org/C206191192","wikidata":"https://www.wikidata.org/wiki/Q17149636","display_name":"NK-92","level":5,"score":0.543023943901062},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4474197328090668},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.4359981417655945},{"id":"https://openalex.org/C28651165","wikidata":"https://www.wikidata.org/wiki/Q4259786","display_name":"Lymphokine-activated killer cell","level":5,"score":0.4340205788612366},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.42082738876342773},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4013720154762268},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.3710514008998871},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.33947810530662537},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.2803792655467987},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2780819535255432},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2540333867073059}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-138527","doi":"https://doi.org/10.1182/blood-2020-138527","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-138527","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413480234","https://openalex.org/W4381799865","https://openalex.org/W4308377683","https://openalex.org/W4396807684","https://openalex.org/W2945258280","https://openalex.org/W6925144458","https://openalex.org/W4308045338","https://openalex.org/W4412186453","https://openalex.org/W7154741893","https://openalex.org/W4413056117"],"abstract_inverted_index":{"Induced":[0],"pluripotent":[1],"stem":[2],"cell":[3,38,45,103,119,128,151,172,208,237,272,307,355,379,454,499,565,577,583],"(iPSC)-derived":[4],"natural":[5,143,393,464],"killer":[6,118],"(iNK)":[7],"cells":[8,25,71,84,133,367,375,387,410,415,468,478,491,506,526,548],"offer":[9],"a":[10,42,50,92,99,242,248,256,348,402,419,459,555,562],"promising":[11],"platform":[12],"for":[13,422,558],"off-the-shelf":[14],"immunotherapy":[15],"against":[16,246,309,476,515],"cancer.":[17],"A":[18],"unique":[19],"benefit":[20],"of":[21,69,82,126,142,170,286,291,297,316,326,333,351,398,408,432,446,482,501,561,591,656,668,717],"iPSC-derived":[22,546],"immune":[23],"effector":[24,44,132,564],"is":[26,89,579],"the":[27,36,66,105,124,140,165,194,220,231,298,390,429,447,534],"possibility":[28],"to":[29,40,48,72,85,95,163,189,228,240,294,312,339,372,401,522,554],"perform":[30],"multiple":[31],"precision":[32],"editing":[33],"steps":[34],"at":[35],"single":[37],"level":[39],"achieve":[41],"homogenous":[43],"population":[46],"tailored":[47],"target":[49,453,505],"desired":[51],"cancer":[52],"type":[53],"and":[54,75,117,149,174,180,186,255,279,336,357,413,470,492,538,585],"equipped":[55],"with":[56,211,230,330,496,569,589],"selected":[57],"functional":[58,61,93,342,406,543,570],"properties.":[59],"These":[60],"edits":[62,176],"are":[63],"superimposed":[64],"on":[65,91,110,463,533,652,664,713],"innate":[67],"reactivity":[68],"NK":[70,83,102,127,150,192,467,547],"stress":[73],"ligands":[74],"MHC":[76,97],"downregulation":[77],"(missing":[78],"self).":[79],"The":[80],"ability":[81],"sense":[86],"missing":[87],"self":[88,96],"based":[90],"calibration":[94],"during":[98,178,277,353,452,581],"process":[100,125],"termed":[101],"education,":[104],"latter":[106],"being":[107],"critically":[108],"dependent":[109],"signaling":[111,259],"through":[112,572],"inhibitory":[113,146,223,461],"receptors,":[114],"including":[115],"CD94/NKG2A":[116],"immunoglobulin-like":[120],"receptors":[121],"(KIR).":[122],"Whereas":[123],"differentiation":[129,179,356,584],"into":[130],"mature":[131,563],"from":[134,226,472],"iPSCs":[135],"has":[136],"been":[137],"well":[138,319],"characterized,":[139],"role":[141,421,557],"variation":[144,213],"in":[145,156,168,181,234,268,344,385,405,425,466,489,545,567,702],"receptor":[147,166,195,224,245,253,300],"expression":[148,233,264,445],"education":[152,352,424,571,578],"remains":[153],"poorly":[154],"defined":[155],"iNK":[157,171,207,236,271,306,345,354,366,374,378,426,434,490,576,582],"cells.":[158,323,427],"We":[159,302],"used":[160],"mass":[161],"cytometry":[162],"map":[164],"repertoire":[167,196],"series":[169],"lines":[173,238,273,380],"genetic":[175,284],"thereof":[177],"vitro":[182],"expansion":[183,358,586],"(Figure":[184,359,395,411,416,507,527],"1A":[185],"B).":[187],"Similar":[188],"peripheral":[190,473],"blood":[191,474],"cells,":[193,346,435],"was":[197,219,265,280,442,486],"diversified":[198],"but":[199,210,274],"genetically":[200,215],"hardwired":[201],"showing":[202],"consistent":[203],"patterns":[204],"within":[205],"each":[206],"line":[209],"slight":[212,460],"between":[214],"distinct":[216],"lines.":[217],"NKG2A":[218,287,292,399],"dominantly":[221],"expressed":[222],"ranging":[225],"13%":[227],"87%":[229],"highest":[232,391],"multi-edited":[235],"engineered":[239,311],"express":[241,313],"chimeric":[243],"antigen":[244],"CD19,":[247],"high":[249],"affinity,":[250],"non-cleavable":[251],"Fc\u03b3RIIIa":[252],"(CD16)":[254],"recombinant":[257],"IL15":[258],"complex":[260],"(CAR19-iNK":[261],"cells).":[262],"KIR":[263],"generally":[266],"low":[267],"all":[269,377],"tested":[270],"increased":[275,282,295],"gradually":[276],"culture":[278],"further":[281],"by":[283,305,444],"silencing":[285,290,325],"receptors.":[288],"Interestingly,":[289],"lead":[293],"levels":[296,315,332,481],"activating":[299],"NKG2C.":[301],"monitored":[303],"degranulation":[304,514],"variants":[308],"K562":[310,477],"varying":[314],"HLA-E":[317,451,502,516],"as":[318,320],"CD19+":[321,504,518],"Nalm-6":[322,519],"Genetic":[324],"\u00df2microglobulin":[327],"(\u00df2m),":[328],"associated":[329],"reduced":[331],"HLA-class":[334],"I":[335],"HLA-E,":[337,483],"led":[338,400],"dampened":[340],"global":[341],"responses":[343],"suggesting":[347],"positive":[349],"impact":[350,462],"1C).":[360],"Subset":[361],"stratification":[362],"revealed":[363],"that":[364,388,541],"NKG2A+":[365,433,497,510],"showed":[368,389,512],"superior":[369,430,513],"functionality":[370,431],"compared":[371,521],"NKG2A-":[373],"across":[376],"tested,":[381],"albeit":[382],"less":[383],"striking":[384],"CAR19-iNK":[386,414,511,525],"overall":[392],"cytotoxicity":[394,465],"1D).":[396],"Knockdown":[397],"general":[403],"reduction":[404],"capacity":[407],"NK92":[409],"1E-F)":[412],"1H),":[417],"supporting":[418],"critical":[420],"NKG2A-driven":[423,559],"Given":[428],"we":[436,457],"next":[437],"addressed":[438],"whether":[439],"this":[440,484],"advantage":[441],"countered":[443],"check":[448],"point":[449,553],"ligand":[450],"interactions.":[455],"Although":[456],"noted":[458],"isolated":[469],"expanded":[471],"(PB-NK)":[475],"expressing":[479,503,517,594],"physiological":[480],"effect":[485],"completely":[487],"overridden":[488],"did":[493],"not":[494],"interfere":[495],"CAR-iNK":[498],"recognition":[500,590],"1G-H).":[508],"Indeed,":[509],"targets":[520,593],"CRISPR-edited":[523],"NKG2A-/-":[524],"1I).":[528],"Our":[529],"results":[530,552],"shed":[531],"light":[532],"regulatory":[535],"gene":[536],"circuits":[537],"cellular":[539],"programs":[540],"determine":[542],"potential":[544],"products.":[549],"Specifically,":[550],"our":[551],"crucial":[556],"acquisition":[560],"phenotype":[566],"combination":[568],"cognate":[573],"ligands.":[574],"Importantly,":[575],"operational":[580],"without":[587],"interfering":[588],"tumor":[592],"HLA-E.":[595],"Figure":[596],"1":[597],"Disclosures":[598],"Cichocki:":[599],"Fate":[600],"Therapeutics,":[601,610,615,624,629,634,639,682,690,695],"Inc:":[602,611,616,625,630,635,640,691,696],"Consultancy,":[603,641,675,707],"Patents":[604,642,676,708],"&":[605,643,677,709],"Royalties,":[606,644,678],"Research":[607,645,679],"Funding.":[608,680],"Mahmood:Fate":[609],"Current":[612,617,621,626,631,636,684,692,697,699],"Employment.":[613,618,622,627,632,637,685,693],"Gaidarova:Fate":[614],"Bjordahl:Fate":[619],"Therapeutics:":[620,687,706],"Chu:Fate":[623],"Groff:Fate":[628],"Denholtz:Fate":[633],"Miller:Fate":[638],"Funding;":[646],"Vycellix:":[647,711],"Consultancy;":[648],"Onkimmune:":[649],"Honoraria,":[650,662],"Membership":[651,663,712],"an":[653,665,714],"entity's":[654,666,715],"Board":[655,667,716],"Directors":[657,669,718],"or":[658,670,719],"advisory":[659,671,720],"committees;":[660,672],"Nektar:":[661],"GT":[673],"Biopharma:":[674],"Lee:Fate":[681],"Inc.:":[683],"Kaufman:Fate":[686],"Consultancy.":[688],"Goodridge:Fate":[689],"Valamehr:Fate":[694],"Employment,":[698],"equity":[700],"holder":[701],"publicly-traded":[703],"company.":[704],"Malmberg:Fate":[705],"Royalties;":[710],"committees.":[721]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-11-09T00:00:00"}